Reuters logo
BRIEF-Hikma Pharma to buy Ben Venue's generic injectables factory
July 24, 2014 / 8:25 AM / in 3 years

BRIEF-Hikma Pharma to buy Ben Venue's generic injectables factory

July 24 (Reuters) - Hikma Pharmaceuticals Plc

* Agreed with Ben Venue Laboratories, Inc. , part of Boehringer Ingelheim Group of companies, to acquire their generic injectables manufacturing site in Bedford, Ohio

* No incremental consideration is payable in relation to Hikma acquiring Ben Venue manufacturing site.

* All manufacturing at Ben Venue site was ceased in December

* Acquisition of assets expected to be slightly dilutive to adjusted EPS in 2014, 2015 and strongly accretive to adjusted EPS from 2016 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below